All Years | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
2014 — 10 Books and Research Papers Citing DrugPatentWatch
Pereira Da Veiga, C. R., Da Veiga, C. P., Del Corso, J. M., & Pimentel, M. A. (2014). More Than One Decade Of Viagra: What Lessons Can Be Learned From Intellectual Property Rights In The Erectile Dysfunction Market? Journal of Innovation, World Scientific.
This paper examines the evolution of Viagra's patent landscape over its first decade, highlighting how intellectual property strategies influenced market dynamics and generic competition. It utilizes DrugPatentWatch data to analyze patent expirations and exclusivities, providing insights into the strategic use of patents in the erectile dysfunction market.
Blumenfeld, P., Pfeffer, R. M., Symon, Z., & Den, R. B. (2014). The Lag Time in Initiating Clinical Testing of New Drugs in Combination with Radiation Therapy, a Significant Barrier to Progress? British Journal of Cancer.
This study investigates the delays in initiating clinical trials for new drug-radiation combinations, identifying patent-related barriers as significant contributors. It references DrugPatentWatch for patent expiration timelines, emphasizing the impact of patent strategies on the pace of clinical research and development.
Schankerman, M. (2014). Alberto Galasso. Hoover Institution.
This paper profiles Alberto Galasso's contributions to the field of intellectual property, particularly in relation to pharmaceutical patents. It cites DrugPatentWatch to illustrate how patent data can inform economic analyses of innovation and market exclusivity in the pharmaceutical industry.
Bhandari, B., & Mehta, B. (2014). Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double–Edged Sword! Recent Patents on Cardiovascular Drug Discovery.
The authors discuss the dual nature of Vorapaxar's patent protection and its implications for market competition and drug accessibility. DrugPatentWatch is cited to provide patent expiration data, highlighting how patent strategies can influence the competitive landscape in cardiovascular therapeutics.
Mills, M. S. (2014). Essays on the Competitive Dynamics of Innovation and Product Quality. ProQuest.
This collection of essays explores how patent strategies affect innovation and product quality in various industries, including pharmaceuticals. DrugPatentWatch is referenced to analyze patent expiration patterns and their effects on market competition and the introduction of generic alternatives.
Semwal, A., & Ramandeep, S. (2014). Preparation, Characterization and Biological Evaluation of Chitosan-Moxifloxacin Prodrugs for Pharmaceuticals. Marmara Pharmaceutical Journal.
The paper focuses on the development of chitosan-moxifloxacin prodrugs and their potential advantages over existing formulations. It cites DrugPatentWatch to assess the patent landscape of moxifloxacin, informing the authors' strategy for introducing a novel formulation into the market.
Friedman, Y. (2014). The Nature of Asian Biopharmaceutical Innovation. Nature Biotechnology.
Friedman analyzes the unique aspects of biopharmaceutical innovation in Asia, including patent strategies and market access. DrugPatentWatch is used to provide comparative patent data, offering insights into how Asian companies navigate patent landscapes to foster innovation.
Chambers, E. E., Fountain, K. J., Smith, N., & Ashraf, L. (2014). Multidimensional LC-MS/MS Enables Simultaneous Quantification of Intact Human Insulin and Five Recombinant Analogs in Human Plasma. Analytical Chemistry.
This technical paper presents a method for quantifying human insulin and its analogs using LC-MS/MS. While not directly focused on patents, it references DrugPatentWatch to discuss the patent status of insulin analogs, providing context for the commercial implications of the new analytical method.
Huang, C. J. (2014). 进口药比国产药贵多少? Consumers' Report.
This article examines the price disparity between imported and domestically produced pharmaceuticals in China. It cites DrugPatentWatch to analyze patent expiration data, shedding light on how patent strategies influence drug pricing and market access.
Rupniewska-Ładyko, A., et al. (2014). Terapia Sekwencyjna w Ostrym Bólu Pooperacyjnym, z Zastosowaniem Oksykodonu z Naloksonem, w Kontekście Badań Klinicznych. Akademia Medycyny.
The authors discuss the clinical benefits of sequential therapy using oxycodone and naloxone for postoperative pain management. DrugPatentWatch is referenced to assess the patent status of the combination therapy, informing the authors' discussion on market exclusivity and potential for generic competition.
